<unk>  is a cholinergic muscarinic agonist that is FDA approved for the treatment of mild to moderate dementia of the Alzheimer's type.   Common adverse reactions include dehydration, aggression, upper and lower GI bleeding, hypokalemia.
Galantamine hydrobromide
Amobarbital sodium
Lacosamide
Chloral hydrate
Zonisamide
Xantinol nicotinate
Secobarbital sodium
Benzonatate